Evelo Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Evelo Biosciences

28/10/2021 14:34

* Evelo Biosciences Inc  EVLO.OQ  reported a quarterly adjusted
loss of 63 cents​​ per share for the quarter ended in September.
The mean expectation of seven analysts for the quarter was for a
loss of 54 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Evelo Biosciences Inc's reported EPS for the quarter was a
loss of 63 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.9% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Evelo Biosciences Inc shares had risen by 14.1% this
quarter and lost 33.6% so far this year.
* The company reported a quarterly loss of $33.73 million.
* Wall Street's median 12-month price target for Evelo
Biosciences Inc is $19.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated October 28 at 01:34 p.m.
 ​All figures in US dollars unless otherwise stated